
|Articles|June 1, 2003
Unoprostone increases outflow facility to reduce IOP
Author(s)Chet Scerra
Fort Lauderdale, FL-An increase in outflow facility appears to be the mechanism by which unoprostone isopropyl ophthalmic solution (Rescula 0.15%, Novartis) reduces IOP, said Carol B. Toris, PhD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Dr. Mali’s top 5 predictions in ophthalmology for 2026
2
Low-dose pilocarpine shrinks pupil without altering accommodation in presbyopia
3
FDA clears Novaliq’s Investigational New Drug application for NOV05
4
2026 from an OD's perspective: What is on the horizon
5



























